To the Editor. —It has recently been found that the frequency of the E4 allele of apolipoprotein E (apo E) is increased (about threefold) in familial and sporadic late-onset Alzheimer's disease (AD).1 Apolipoprotein E is encoded by a single gene on chromosome 19; a common polymorphism is determined by alleles E2, E3, and E4. The frequency of apo E E4 is around 0.10 to 0.16 in the general elderly population, and 0.36 to 0.48 in late-onset AD patients. This observation has given rise to a number of ethical and scientific questions regarding the necessity and meaning of apo E phenotyping in the general population. However, the specificity of risk is unknown.We assessed the frequency of apo E alleles in 87 AD and 21 vascular dementia patients and in 51 elderly hyperlipidemic nondemented controls. Diagnosis of probable AD (Mini-Mental State Examination score, 10.4 [SD,
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.